Saldi, Jomani .

HRN: 28-90-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/26/2026
05/03/2026
IV
500
Q6
Tetanus
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: